^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
WB100
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Weben Pharma
Drug class:
MYC inhibitor
Related drugs:
Phase 1
Zhejiang University
Recruiting
Last update posted :
01/26/2023
Initiation :
10/25/2021
Primary completion :
10/25/2023
Completion :
10/25/2023
MYC • CA 19-9
|
MYC overexpression • MYC expression • MYC positive
|
WB100
Share
